NASDAQ:BCAB
BioAtla, Inc.
- Stock
Last Close
1.82
30/08 20:00
Market Cap
68.32M
Beta: 0.21
Volume Today
452.17K
Avg: 526.57K
PE Ratio
−0.98
PFCF: −1.19
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | |||||||
average payables | 3.55M - | 3.80M 6.97% | 1.82M 52.14% | 2.71M 48.83% | 2.12M 21.79% | ||
average receivables | |||||||
book value per share | -1.32 - | -2.59 96.61% | 24.91 1,061.06% | 6.10 75.52% | 4.63 24.05% | 0.00 99.97% | |
capex per share | -0.05 - | -0.07 52.73% | -0.07 0.15% | -0.03 61.81% | -0.01 74.25% | -0.00 99.97% | |
capex to depreciation | -1.24 - | -1.75 41.01% | -0.59 66.64% | -0.69 18.69% | -0.22 67.83% | -0.08 64.09% | |
capex to operating cash flow | 0.03 - | 0.16 459.26% | 0.02 89.62% | 0.01 8.54% | 0.00 80.04% | 0.00 68.21% | |
capex to revenue | -0.09 - | -0.29 212.13% | -1.38 373.92% | -3.70 168.74% | |||
cash per share | 0.50 - | 0.17 65.90% | 28.31 16,400.65% | 7.09 74.96% | 5.54 21.90% | 0.00 99.96% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | |||||||
debt to assets | 0.90 - | 1.94 115.27% | 0.00 99.86% | 0.02 658.18% | 0.02 16.46% | 0.02 16.57% | |
debt to equity | -0.53 - | -0.32 38.56% | 0.00 101.00% | 0.03 684.37% | 0.02 13.35% | 0.03 57.68% | |
dividend yield | |||||||
earnings yield | -0.04 - | -0.05 8.36% | -0.13 177.07% | -0.14 8.24% | -0.33 133.12% | ||
enterprise value | 673.82M - | 684.09M 1.53% | 48.72M 92.88% | 438.83M 800.74% | 109.62M 75.02% | 117.42B 107,015.09% | |
enterprise value over ebitda | -24.74 - | -25.06 1.28% | -1.68 93.29% | -4.63 175.59% | -1.03 77.77% | -905.44 87,848.90% | |
ev to operating cash flow | -19.08 - | -70.93 271.75% | -1.34 98.11% | -7.05 426.05% | -1.21 82.81% | -1.13K 93,014.90% | |
ev to sales | 63.41 - | 131.56 107.48% | 113.56 13.68% | 1.76K 1,445.68% | |||
free cash flow per share | -1.68 - | -0.52 69.28% | -4.38 747.95% | -1.83 58.30% | -2.33 27.52% | -0.00 99.91% | |
free cash flow yield | -0.05 - | -0.02 69.28% | -0.13 673.40% | -0.09 27.75% | -0.28 203.43% | -0.00 99.69% | |
graham net net | -1.59 - | -2.86 80.14% | 24.16 946.21% | 5.83 75.88% | 4.37 25.00% | 0.00 99.97% | |
graham number | 6.31 - | 9.21 45.96% | 49.77 440.32% | 19.46 60.89% | 16.79 13.74% | ||
income quality | 1.22 - | 0.32 73.49% | 1.01 213.69% | 0.65 35.65% | 0.85 30.21% | 0.84 0.79% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -29.75 - | -17.34 41.71% | -21.67 24.95% | -32.15K 148,249.51% | 65.22 100.20% | ||
interest debt per share | 0.74 - | 0.91 23.83% | 0.25 73.14% | 0.16 36.72% | 0.06 61.62% | 0.00 99.91% | |
inventory turnover | |||||||
invested capital | -0.53 - | -0.32 38.56% | 0.00 101.00% | 0.03 684.37% | 0.02 13.35% | 0.03 57.68% | |
market cap | 669.68M - | 669.68M 0% | 286.64M 57.20% | 678.44M 136.68% | 321.15M 52.66% | 117.53B 36,497.49% | |
net current asset value | -32.42M - | -60.84M 87.66% | 205.72M 438.13% | 203.69M 0.99% | 175.03M 14.07% | 67.42M 61.48% | |
net debt to ebitda | -0.15 - | -0.53 247.62% | 8.21 1,654.20% | 2.53 69.19% | 1.99 21.44% | 0.84 57.69% | |
net income per share | -1.34 - | -1.45 8.36% | -4.42 203.78% | -2.76 37.53% | -2.70 2.02% | ||
operating cash flow per share | -1.64 - | -0.45 72.69% | -4.31 864.95% | -1.80 58.24% | -2.32 29.04% | -0.00 99.91% | |
payables turnover | |||||||
receivables turnover | |||||||
research and ddevelopement to revenue | 2.48 - | 4.98 101.37% | 46.46 832.18% | 233.10 401.67% | |||
return on tangible assets | -1.74 - | -3.36 93.10% | -0.15 95.48% | -0.37 146.63% | -0.47 24.38% | ||
revenue per share | 0.49 - | 0.24 51.07% | 0.05 78.87% | 0.01 85.79% | |||
roe | 1.02 - | 0.56 44.88% | -0.18 131.61% | -0.45 155.16% | -0.58 29.01% | ||
roic | 2.11 - | 0.79 62.79% | -0.15 118.89% | -0.44 193.29% | -0.57 30.45% | ||
sales general and administrative to revenue | 1.18 - | 1.45 22.87% | 24.70 1,601.21% | 153.66 522.20% | |||
shareholders equity per share | -1.32 - | -2.59 96.61% | 24.91 1,061.06% | 6.10 75.52% | 4.63 24.05% | 0.00 99.97% | |
stock based compensation to revenue | 7.04 - | 100.47 1,326.23% | |||||
tangible asset value | -28.45M - | -56.01M 96.90% | 209.97M 474.88% | 210.82M 0.40% | 180.34M 14.46% | 70.67M 60.81% | |
tangible book value per share | -1.32 - | -2.59 96.90% | 24.91 1,060.25% | 6.10 75.52% | 4.63 24.05% | 0.00 99.97% | |
working capital | 3.47M - | -22.21M 740.83% | 208.42M 1,038.36% | 227.48M 9.14% | 197.30M 13.27% | 88.06M 55.37% |
All numbers in USD (except ratios and percentages)